secwatch.observer — SEC 8-K summary
======================================

Issuer:     Shattuck Labs, Inc. (STTK)
CIK:        0001680367
Form:       8-K
Filed at:   2026-01-22T23:59:59+00:00
Accession:  0001193125-26-019682
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shattuck Labs enters $75M ATM equity distribution agreement with Leerink Partners
--------------------------------------------------------------------------------

- Entered Sales Agreement with Leerink Partners for at-the-market offering of up to $75M of common stock.
- Shares sold at market prices; company not obligated to sell any shares.
- Proceeds to fund ongoing/planned clinical trials and for working capital/general corporate purposes.
- Agent commission of up to 3% of gross sales price plus reimbursement of expenses.
- Registration statement on Form S-3 declared effective January 21, 2026; prospectus supplement filed January 22, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1680367/000119312526019682/0001193125-26-019682-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1680367/000119312526019682/d59331d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-019682

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer